Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Diagnosing diabetes mellitus in patients with porphyria cutanea tarda

Diagnosing diabetes mellitus in patients with porphyria cutanea tarda The prevalence of diabetes mellitus is increased in patients with porphyria cutanea tarda. Different tests are available for diagnosing and screening for type II diabetes mellitus, however choosing the most suitable test is challenging. The pitfalls in the different tests along with the interfering comorbidities and treatments concerning patients with porphyria cutanea tarda complicate diagnosing these patients with diabetes mellitus. HbA1c, fasting glucose, or oral glucose tolerance are the current available tests, with HbA1c as first choice. Measuring HbA1c requires no fasting, however HbA1c can be false low if the patient is treated with phlebotomy or has liver cirrhosis or chronic hepatitis. Instead fasting glucose and oral glucose tolerance tests can be used if the patient is not acutely ill. If either of the tests give a result in the diagnostic range, the test should be repeated if the patient has no clinical symptoms of diabetes. Diagnosing diabetes mellitus is important for the purpose of early intervention, and this review provides the knowledge needed to diagnose this special patient group properly. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Dermatology Wiley

Diagnosing diabetes mellitus in patients with porphyria cutanea tarda

Download PDF
7 pages

Loading next page...
 
/lp/wiley/diagnosing-diabetes-mellitus-in-patients-with-porphyria-cutanea-tarda-xQpJFLXk2b
Publisher
Wiley
Copyright
International Journal of Dermatology © 2018 International Society of Dermatology
ISSN
0011-9059
eISSN
1365-4632
DOI
10.1111/ijd.13938
pmid
29516487
Publisher site
See Article on Publisher Site

Abstract

The prevalence of diabetes mellitus is increased in patients with porphyria cutanea tarda. Different tests are available for diagnosing and screening for type II diabetes mellitus, however choosing the most suitable test is challenging. The pitfalls in the different tests along with the interfering comorbidities and treatments concerning patients with porphyria cutanea tarda complicate diagnosing these patients with diabetes mellitus. HbA1c, fasting glucose, or oral glucose tolerance are the current available tests, with HbA1c as first choice. Measuring HbA1c requires no fasting, however HbA1c can be false low if the patient is treated with phlebotomy or has liver cirrhosis or chronic hepatitis. Instead fasting glucose and oral glucose tolerance tests can be used if the patient is not acutely ill. If either of the tests give a result in the diagnostic range, the test should be repeated if the patient has no clinical symptoms of diabetes. Diagnosing diabetes mellitus is important for the purpose of early intervention, and this review provides the knowledge needed to diagnose this special patient group properly.

Journal

International Journal of Dermatology – Wiley

Published: Jan 1, 2018

References

  • Porphyrias
    Puy, H; Gouya, L; Deybach, JC
  • Cutaneous porphyrias: causes, symptoms, treatments and the Danish incidence 1988–2013
    Christiansen, AL; Aagaard, L; Krag, A
  • Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies
    Aarsand, AK; Boman, H; Sandberg, S
  • Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status
    Bygum, A; Christiansen, L; Petersen, NE
  • Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene
    Mendez, M; Poblete‐Gutierrez, P; Garcia‐Bravo, M
  • Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects
    Elder, GH; Roberts, AG; Salamanca, RE
  • Porphyria cutanea tarda in a Swedish population: risk factors and complications
    Rossmann‐Ringdahl, I; Olsson, R
  • Associations among behavior‐related susceptibility factors in porphyria cutanea tarda
    Jalil, S; Grady, JJ; Lee, C
  • Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America
    Bonkovsky, HL; Poh‐Fitzpatrick, M; Pimstone, N
  • Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection
    Martinelli, AL; Zago, MA; Roselino, AM
  • The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm
    Linde, Y; Harper, P; Floderus, Y
  • The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long‐term follow‐up cohort
    Munoz‐Santos, C; Guilabert, A; Moreno, N
  • Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease
    Fracanzani, AL; Taioli, E; Sampietro, M
  • Porphyria cutanea tarda and diabetes
    Rook, A; Champion, RH
  • Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients
    Grossman, ME; Bickers, DR; Poh‐Fitzpatrick, MB
  • Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients
    Munoz‐Santos, C; Guilabert, A; Moreno, N
  • Carbohydrate metabolism in porphyria cutanea tarda
    Franks, AG; Pulini, M; Bickers, DR
  • Insulin resistance in porphyria cutanea tarda
    Calcinaro, F; Basta, G; Lisi, P
  • Glucose tolerance in adult Ethiopian patients with liver disease and porphyria cutanea tarda
    Mengistu, M; Gebreselassie, F; Tsega, E
  • Carbohydrate metabolism in porphyria cutanea tarda
    Lisi, P; Santeusanio, F; Lombardi, G
  • Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test‐based population study
    Castell, C; Tresserras, R; Serra, J
  • Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis
    Harris, MI; Klein, R; Welborn, TA
  • Type 2 diabetes
    Chatterjee, S; Khunti, K; Davies, MJ
  • Diagnosis and classification of diabetes mellitus
  • Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta‐analysis of 102 prospective studies
    Sarwar, N; Gao, P; Seshasai, SR
  • Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus
    Sacks, DB; Arnold, M; Bakris, GL
  • Classification and diagnosis of diabetes
  • Review of hemoglobin A(1c) in the management of diabetes
    Gallagher, EJ; Le Roith, D; Bloomgarden, Z
  • Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis
    Nakao, T; Matsumoto, H; Okada, T
  • Effect of iron deficiency anemia and iron supplementation on HbA1c levels ‐ Implications for diagnosis of prediabetes and diabetes mellitus in Asian Indians
    Madhu, SV; Raj, A; Gupta, S
  • Glycosylated haemoglobin (HbA1c) in iron‐ and vitamin B12 deficiency
    Gram‐Hansen, P; Eriksen, J; Mourits‐Andersen, T
  • Whole blood donation affects the interpretation of hemoglobin A1c
    Dijkstra, A; Lenters‐Westra, E; Kort, W
  • Effects of phlebotomy‐induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial
    Houschyar, KS; Ludtke, R; Dobos, GJ
  • Blood letting in high‐ferritin type 2 diabetes: effects on insulin sensitivity and beta‐cell function
    Fernandez‐Real, JM; Penarroja, G; Castro, A
  • Determination of glycated hemoglobin in patients with advanced liver disease
    Lahousen, T; Hegenbarth, K; Ille, R
  • Hepatitis C, porphyria cutanea tarda and liver iron: an update
    Ryan Caballes, F; Sendi, H; Bonkovsky, HL
  • The relationship between HbA1c and fasting plasma glucose in patients with increased plasma liver enzyme measurements
    Christiansen, R; Rasmussen, LM; Nybo, H
  • Glycosylated hemoglobin in chronic alcoholics
    Proto, G; De Marchi, S; Cecchin, E
  • Association between alcohol intake and hemoglobin A1c in the Korean adults: the 2011–2013 Korea National Health and Nutrition Examination Survey
    Hong, JW; Noh, JH; Kim, DJ
  • Hemoglobin variants and determination of glycated hemoglobin (HbA1c)
    Schnedl, WJ; Liebminger, A; Roller, RE
  • Diagnosis and classification of diabetes mellitus
  • Effects of fasting and glucose load on free cortisol responses to stress and nicotine
    Kirschbaum, C; Gonzalez Bono, E; Rohleder, N
  • Short‐term variability in measures of glycemia and implications for the classification of diabetes
    Selvin, E; Crainiceanu, CM; Brancati, FL
  • Report of the Expert Committee on the Diagnosis, and Classification of Diabetes Mellitus
    Gavin, JR; Alberti, KG; Davidson, MB; DeFronzo, RA
  • Comparing glucose and hemoglobin A1c diagnostic tests among a high metabolic risk Hispanic population
    Vega‐Vazquez, MA; Ramirez‐Vick, M; Munoz‐Torres, FJ